Asset
SB-743921
Cytokinetics Incorporated Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00343564 | phase1_2 | completed | 2006-04-01 | 2010-07-01 | Cytokinetics | A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma |
FDA applications (0)
This company has no applications containing this asset.